160 related articles for article (PubMed ID: 18941834)
1. Lung cancer and renal insufficiency: prevalence and anticancer drug issues.
Launay-Vacher V; Etessami R; Janus N; Spano JP; Ray-Coquard I; Oudard S; Gligorov J; Pourrat X; Beuzeboc P; Deray G; Morere JF;
Lung; 2009; 187(1):69-74. PubMed ID: 18941834
[TBL] [Abstract][Full Text] [Related]
2. Drug management of prostate cancer: prevalence and consequences of renal insufficiency.
Launay-Vacher V; Ayllon J; Janus N; Spano JP; Ray-Coquard I; Gligorov J; Pourrat X; Morere JF; Beuzeboc P; Deray G; Oudard S;
Clin Genitourin Cancer; 2009 Oct; 7(3):E83-9. PubMed ID: 19815487
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study.
Launay-Vacher V; Oudard S; Janus N; Gligorov J; Pourrat X; Rixe O; Morere JF; Beuzeboc P; Deray G;
Cancer; 2007 Sep; 110(6):1376-84. PubMed ID: 17634949
[TBL] [Abstract][Full Text] [Related]
4. Cancer and renal insufficiency results of the BIRMA study.
Janus N; Launay-Vacher V; Byloos E; Machiels JP; Duck L; Kerger J; Wynendaele W; Canon JL; Lybaert W; Nortier J; Deray G; Wildiers H
Br J Cancer; 2010 Dec; 103(12):1815-21. PubMed ID: 21063408
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues.
Launay-Vacher V; Gligorov J; Le Tourneau C; Janus N; Spano JP; Ray-Coquard I; Oudard S; Pourrat X; Morere JF; Deray G; Beuzeboc P;
Breast Cancer Res Treat; 2010 Dec; 124(3):745-53. PubMed ID: 18704681
[TBL] [Abstract][Full Text] [Related]
6. Renal insufficiency and anticancer drugs in elderly cancer patients: a subgroup analysis of the IRMA study.
Launay-Vacher V; Spano JP; Janus N; Gligorov J; Ray-Coquard I; Oudard S; Pourrat X; Morere JF; Beuzeboc P; Deray G;
Crit Rev Oncol Hematol; 2009 May; 70(2):124-33. PubMed ID: 18990585
[TBL] [Abstract][Full Text] [Related]
7. [Renal insufficiency and breast cancer].
Beuzeboc P; Le Tourneau C; Gligorov J; Janus N; Spano JP; Ray-Coquard I; Deray G; Launay-Vacher V
Bull Cancer; 2012 Mar; 99(3):309-15. PubMed ID: 22106161
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of methods for evaluating renal function (Data of Kaunas University of Medicine Hospital in 2006)].
Kuzminskis V; Skarupskiene I; Bumblyte IA; Kardauskaite Z; Uogintaite J
Medicina (Kaunas); 2007; 43 Suppl 1():46-51. PubMed ID: 17551276
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of renal impairment and use of nephrotoxic agents among patients with bone metastases from solid tumors in the United States.
Arellano J; Hernandez RK; Wade SW; Chen K; Pirolli M; Quach D; Quigley J; Liede A; Shahinian VB
Cancer Med; 2015 May; 4(5):713-20. PubMed ID: 25663171
[TBL] [Abstract][Full Text] [Related]
10. Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study.
Karie S; Gandjbakhch F; Janus N; Launay-Vacher V; Rozenberg S; Mai Ba CU; Bourgeois P; Deray G
Rheumatology (Oxford); 2008 Mar; 47(3):350-4. PubMed ID: 18238787
[TBL] [Abstract][Full Text] [Related]
11. Monitoring the estimated glomerular filtration rate (eGFR) in patients with small-cell lung cancer during chemotherapy: equations based on serum creatinine or cystatin C?
Tian X; Zhang X; Yu M; Lu Y; Ding Z; Huang M; Peng F; Ren L; Wang J; Wang Y; Xu Y; Zhu J; Zhou L; Zhou X; Deng M; Tang X; Gong Y
Int J Clin Oncol; 2018 Apr; 23(2):258-265. PubMed ID: 29103151
[TBL] [Abstract][Full Text] [Related]
12. Renal insufficiency in Ghanaian HIV infected patients: need for dose adjustment.
Owiredu WK; Quaye L; Amidu N; Addai-Mensah O
Afr Health Sci; 2013 Mar; 13(1):101-11. PubMed ID: 23658575
[TBL] [Abstract][Full Text] [Related]
13. [Incidence, risk factors and prevention of cisplatin-induced nephrotoxicity in patients with lung cancer].
Losonczy G; Máthé C; Müller V; Szondy K; Moldvay J
Magy Onkol; 2010 Dec; 54(4):289-96. PubMed ID: 21163759
[TBL] [Abstract][Full Text] [Related]
14. Renal insufficiency, mortality, and drug management in heart transplant. Results of the CARIN study.
Janus N; Launay-Vacher V; Sebbag L; Despins P; Epailly E; Pavie A; Obadia JF; Pattier S; Varnous S; Pezzella V; Trillaud L; Deray G; Guillemain R
Transpl Int; 2014 Sep; 27(9):931-8. PubMed ID: 24853579
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy and renal toxicity].
Launay-Vacher V; Isnard-Bagnis C; Janus N; Karie S; Deray G
Bull Cancer; 2008 May; 95 FMC Onco():F96-103. PubMed ID: 18511375
[TBL] [Abstract][Full Text] [Related]
16. Estimating the prevalence of renal insufficiency in seniors requiring long-term care.
Garg AX; Papaioannou A; Ferko N; Campbell G; Clarke JA; Ray JG
Kidney Int; 2004 Feb; 65(2):649-53. PubMed ID: 14717937
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of renal insufficiency in elderly cancer patients in a tertiary cancer center.
Pontes Lde B; Antunes YP; Bugano DD; Karnakis T; Giglio AD; Kaliks RA
Einstein (Sao Paulo); 2014 Sep; 12(3):300-3. PubMed ID: 25295449
[TBL] [Abstract][Full Text] [Related]
18. [Clarification of the method used for drug dosage adjustment in patients with renal failure: The CLEAR study].
Berdougo J; Delorière É; Deray G; Launay-Vacher V
Nephrol Ther; 2020 Feb; 16(1):59-64. PubMed ID: 31987727
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of renal insufficiency and factors associated among selected cancer patients on chemotherapy at Ocean Road Cancer Institute in Tanzania: a cross-sectional study.
Rajabu HN; Hinderaker SG; Mnandi P; Mutagonda RF
BMC Cancer; 2024 Jun; 24(1):763. PubMed ID: 38918707
[TBL] [Abstract][Full Text] [Related]
20. Importance of monitoring renal function in patients with cancer.
Aapro M; Launay-Vacher V
Cancer Treat Rev; 2012 May; 38(3):235-40. PubMed ID: 21605937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
